\n
Optimise outcomes – change the clinical course for your patients<\/h2>\n
MPS disorders are complex, multisystemic conditions whose unique risks and life\u2013altering complications require careful, coordinated care from a multidisciplinary team of specialists.1-5<\/sup> The emergence of specific therapies for some MPS disorders has elevated the critical nature of early intervention and diagnosis as key components of optimal, long-term outcomes.1,2,3,6,7<\/sup><\/p>\n Manage your patients with MPS <\/a><\/p>\n <\/div>\n \n \n \n \n \n \n
\n \n

<\/div>\n <\/figure>\n <\/div>\n \t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n\t
\n\t\t
\n\t\t\t
\n\t\t\t \t\t\t\t\t\t\t<\/div>\n\t\t\t
\n\t\t\t \t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n
\n
\n\t\t
\n\t\t \t\t\t
References:\n<\/h4>\n\t\t\t\t\t\t \n - Lehman TJA et al. Diagnosis of the mucopolysaccharidoses. Rheumatology. 2011;50(suppl 5):v41\u2013v48\n<\/span><\/li>\n
- Muenzer J, Wraith JE, Clarke LA, International Consensus Panel on the Management and Treatment of Mucopolysaccharidosis I. Mucopolysaccharidosis I: management and treatment guidelines. Pediatrics. 2009;123(1):19\u201329. doi:10.1542\/peds.2008-0416.\n<\/span><\/li>\n
- Muenzer J, Beck M, Eng CM, et al.Genet Med. 2011;13(2):95\u2013101. doi:10.1097\/GIM.0b013e3181fea459.\n<\/span><\/li>\n
- Klitzner TS, Rabbitt LA, Chang RKR. Benefits of care coordination for children with complex disease: a pilot medical home project in a resident teaching clinic. J Pediatr. 2010;156(6):1006\u20131010. doi:10.1016\/j.jpeds.2009.12.012.\n<\/span><\/li>\n
- Mosquera RA, Avritscher EBC, Samuels CL, et al. Effect of an enhanced medical home on serious illness and cost of care among high-risk children with chronic illness: a randomized clinical trial. JAMA. 2014;312(24):2640\u20132648. doi:10.1001\/jama.2014.16419. \n<\/span><\/li>\n
- Clarke LA. Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator. Rheumatology (Oxford). 2011;50(suppl 5):v13\u201318. doi:10.1093\/rheumatology\/ker395.\n<\/span><\/li>\n
- Morishita K, Petty RE. Musculoskeletal manifestations of mucopolysaccharidoses. Rheumatology. 2011;50(suppl 5):v19\u2013v25. doi:10.1093\/rheumatology\/ker397.\n<\/span><\/li>\n <\/ol>\n\t\t\t\t\t<\/div>\n\t<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-12","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"\nHome - BioMarin MPS DSE HCP EN-GB<\/title>\n\n\n\n\n\n\n\n\n\n